Notice of Proposed Derivative Settlement: Twist Bioscience Corporation
Business Wire•03/11/2026•16:05 ET
0
Key Highlights
- ➤Proposed settlement requires Twist’s Board to implement corporate governance reforms.
- ➤Settlement Hearing set for January 22, 2027, in Delaware federal court.
- ➤Plaintiffs’ Counsel seeks $1,000,000 in fees and expenses from insurers.
- ➤Two plaintiffs may receive service awards of up to $2,000 each.
Notice of Proposed Derivative Settlement: Twist Bioscience Corporation
DISTRICT OF DELAWARE IN RE TWIST BIOSCIENCE CORPORATION Lead Case No. 1:23-cv-01048-MN
Get started
Create a free account to read the full story.